Mesentech Drug C3 will be tested aboard International Space Station
The ISS National Lab will be testing Mesentech's bone-anabolic compounds on the International Space Station for their potential to reverse osteoporosis related to weightlessness in space. This research is being being conducted with the support of the Center for the Advancement of Science in Space in collaboration with Houston Methodist Hospital. Tentative launch date is January 2020 from Kennedy Space Center in Florida aboard a SpaceX Dragon.